TAPBPL

TAP binding protein like, the group of C1-set domain containing

Basic information

Region (hg38): 12:6451690-6466517

Links

ENSG00000139192NCBI:55080OMIM:607081HGNC:30683Uniprot:Q9BX59AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TAPBPL gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TAPBPL gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
19
clinvar
1
clinvar
20
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 19 1 0

Variants in TAPBPL

This is a list of pathogenic ClinVar variants found in the TAPBPL region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-6453067-A-G not specified Uncertain significance (Sep 01, 2021)2248327
12-6453081-G-A not specified Uncertain significance (Jan 03, 2024)3173822
12-6453284-C-G not specified Uncertain significance (Oct 27, 2022)2393666
12-6453286-T-C not specified Uncertain significance (May 31, 2023)2554272
12-6453473-G-A not specified Uncertain significance (Feb 05, 2024)3173820
12-6453527-C-T not specified Uncertain significance (Mar 27, 2023)2530147
12-6453645-C-T not specified Uncertain significance (May 17, 2023)2547076
12-6453677-A-C Marfanoid habitus and intellectual disability Uncertain significance (-)689676
12-6453708-G-A not specified Likely benign (Dec 16, 2023)3173821
12-6453713-G-A not specified Uncertain significance (Jun 29, 2022)2236346
12-6457472-A-T not specified Uncertain significance (Oct 04, 2022)2316259
12-6457489-G-A not specified Uncertain significance (Oct 20, 2021)2256089
12-6457523-G-A not specified Uncertain significance (Mar 27, 2023)2560975
12-6457588-C-T not specified Uncertain significance (Dec 21, 2022)2217515
12-6457589-G-A not specified Uncertain significance (Apr 13, 2023)2509747
12-6458681-C-T not specified Uncertain significance (Jun 07, 2023)2559122
12-6458936-T-C not specified Uncertain significance (Dec 16, 2021)2267616
12-6460857-C-T not specified Uncertain significance (Nov 22, 2022)2218730
12-6462085-G-A not specified Uncertain significance (Sep 16, 2021)2250485
12-6462127-C-T not specified Uncertain significance (Oct 06, 2021)2226129
12-6462840-G-A Benign/Likely benign (Jan 01, 2024)448851
12-6462882-A-G Myasthenic syndrome, congenital, 25, presynaptic • Spastic ataxia 1 Benign (Dec 05, 2021)1234868
12-6463025-T-C Benign (May 15, 2021)1253157
12-6464474-G-A Spastic paraplegia Uncertain significance (Aug 22, 2022)1440899
12-6464476-A-G Spastic paraplegia Likely benign (Aug 16, 2022)2057138

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TAPBPLprotein_codingprotein_codingENST00000266556 714828
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.31e-100.25412562301241257470.000493
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7792312670.8660.00001442975
Missense in Polyphen4760.8720.77212725
Synonymous0.1021131140.9880.000006651013
Loss of Function0.7791720.80.8160.00000132186

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0008450.000841
Ashkenazi Jewish0.0004170.000397
East Asian0.0002180.000217
Finnish0.001250.00125
European (Non-Finnish)0.0002540.000237
Middle Eastern0.0002180.000217
South Asian0.001150.00111
Other0.0004990.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the antigen processing and presentation pathway, which binds to MHC class I coupled with beta2- microglobulin/B2M. Association between TAPBPR and MHC class I occurs in the absence of a functional peptide-loading complex (PLC). Expression seems to slow down and down-regulate MHC class I surface expression. {ECO:0000269|PubMed:23401559}.;

Recessive Scores

pRec
0.0840

Intolerance Scores

loftool
0.883
rvis_EVS
0.98
rvis_percentile_EVS
90.39

Haploinsufficiency Scores

pHI
0.0481
hipred
N
hipred_score
0.123
ghis
0.402

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.368

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tapbpl
Phenotype

Gene ontology

Biological process
immune system process;negative regulation of antigen processing and presentation of peptide antigen via MHC class I
Cellular component
Golgi membrane;endoplasmic reticulum membrane;plasma membrane;integral component of membrane
Molecular function
protein binding;protein-containing complex binding